Literature DB >> 7940132

Microvasculature of the anterior optic nerve.

G A Cioffi1, E M Van Buskirk.   

Abstract

The traditional definition of glaucoma as a disorder of increased intraocular pressure (IOP) oversimplifies the clinical situation. Some glaucoma patients never have higher than normal IOP and others continue to develop optic nerve damage despite maximal lowering of IOP. Another possible factor in the etiology of glaucoma may be regulation of the regional microvasculature of the anterior optic nerve. One reason to believe that microvascular factors are important is that many microvascular diseases are associated with glaucomatous optic neuropathy. In this study, endothelin-1 was used to produce vasoconstriction of the ocular vasculature following both intravitreal and perineural delivery. Intravitreal injections (1.25 and 2.50 micrograms) were given to six rabbits to assess the vascular response of the posterior segment. In addition, endothelin (0.0-4.2 micrograms) was delivered with an osmotically driven minipump system to the perineural region of six rabbits. Vasoconstriction of the anterior optic nerve vasculature was observed following both methods of endothelin delivery. A better understanding of the microvasculature of the anterior optic nerve is needed to evaluate its relationship to glaucomatous damage. Modulation of this vascular supply, with agents that mimic autoregulatory controls, may allow the sites of vasomotor control to be established and, in the future, their status to be manipulated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940132     DOI: 10.1016/0039-6257(94)90054-x

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  11 in total

1.  The effects of graded intraocular pressure challenge on the optic nerve head.

Authors:  Nimesh Patel; Faith McAllister; Laura Pardon; Ronald Harwerth
Journal:  Exp Eye Res       Date:  2018-02-01       Impact factor: 3.467

2.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 3.  Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma.

Authors:  John C Morrison; William O Cepurna Ying Guo; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2010-08-11       Impact factor: 3.467

Review 4.  Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses.

Authors:  Steven L Bernstein; Neil R Miller
Journal:  Jpn J Ophthalmol       Date:  2015-02-18       Impact factor: 2.447

5.  Prevention of visual field defects after macular hole surgery.

Authors:  A B Cullinane; P E Cleary
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

6.  Integrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis).

Authors:  John C Morrison
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Matrix metalloproteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model.

Authors:  Zeynep Aktas; Gokhan Gurelik; Pinar Uyar Göçün; Nalan Akyürek; Merih Onol; Berati Hasanreisoğlu
Journal:  Int Ophthalmol       Date:  2009-07-21       Impact factor: 2.031

8.  Ischaemia in the Zinn-Haller circle and glaucomatous optic neuropathy in macaque monkeys.

Authors:  Mari Hiraoka; Kenichi Inoue; Taihei Ninomiya; Masahiko Takada
Journal:  Br J Ophthalmol       Date:  2012-01-04       Impact factor: 4.638

9.  Increased expression of oxyproteins in the optic nerve head of an in vivo model of optic nerve ischemia.

Authors:  Joon Mo Kim; Yu Jeong Kim; Dong Myung Kim
Journal:  BMC Ophthalmol       Date:  2012-12-05       Impact factor: 2.209

10.  A prospective profile of visual field loss following stroke: prevalence, type, rehabilitation, and outcome.

Authors:  Fiona J Rowe; David Wright; Darren Brand; Carole Jackson; Shirley Harrison; Tallat Maan; Claire Scott; Linda Vogwell; Sarah Peel; Nicola Akerman; Caroline Dodridge; Claire Howard; Tracey Shipman; Una Sperring; Sonia Macdiarmid; Cicely Freeman
Journal:  Biomed Res Int       Date:  2013-09-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.